1-4 of 4
Qingxiu Zhong, MD
Close
Sort by
Journal Articles

Hh/IGF-1R/PI3K/Akt/MRP1 Pathway Induce Refractory Acute Myeloid Leukemia and Its Targeting Therpy

Kaikai Huang, Bingjie Ding, MD, Qingxiu Zhong, MD, Xuejie Jiang, MDPhD, Xiaodong Li, MD, Zhixiang Wang, MD, Fan Yi Meng, MD
Journal: Blood
Blood (2014) 124 (21): 3612.
https://doi.org/10.1182/blood.V124.21.3612.3612
Published: 2014
Journal Articles

Molecular Mechanisms of EML in AML1/ETO+ AML and Its Targeting Treatments

Fan Yi Meng, MD, Ling Jiang, MD PhD, Qingxiu Zhong, MD, Li Chun Wang, MD, Guopan Yu, MD, Xinhua Zhu, MD
Journal: Blood
Blood (2014) 124 (21): 5953.
https://doi.org/10.1182/blood.V124.21.5953.5953
Published: 2014
Journal Articles

Decitabine Act As Demethylation Modulators in Acute Myeloid Leukemia for Reversal of Drug Resistance

Zhixiang Wang, MD, Xuejie Jiang, MDPhD, Kaikai Huang, Changxin Yin, Qingxiu Zhong, MD, Qiuhua Zhu, MD, Bingjie Ding, MD, Fan Yi Meng, MD
Journal: Blood
Blood (2014) 124 (21): 5218.
https://doi.org/10.1182/blood.V124.21.5218.5218
Published: 2014
Journal Articles

APP Gene Is Correlated with C-KIT Mutations and Indicates Poor Disease Outcome in AML1-ETO-Positive Acute Myeloid Leukemia

Guopan Yu, MD, Ling Jiang, MDPhD, Fan Yi Meng, MD, Changxin Yin, Zhixiang Wang, MD, Hongsheng Zhou, MDPhD, Xuejie Jiang, MDPhD, Qingxiu Zhong, MD, Rui Cao, Libin Liao
Journal: Blood
Blood (2014) 124 (21): 942.
https://doi.org/10.1182/blood.V124.21.942.942
Published: 2014